Thermodynamic approach to oxygen delivery in vivo by natural and artificial oxygen carriers

被引:10
|
作者
Bucci, Enrico [1 ]
机构
[1] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA
关键词
Blood flow; Oxygen delivery; Oxygen gradients; Facilitated diffusion; Oxygen carriers; Blood substitutes; HEMOGLOBINS; TRANSPORT; AFFINITY; LEAKAGE; BLOOD; VITRO;
D O I
10.1016/j.bpc.2008.12.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
oxygen is a toxic gas, still indispensable to aerobic life. This paper explores how normal physiology uses the physico-chemical and thermodynamic characteristics of oxygen for transforming a toxic gas into a non toxic indispensable metabolite. Plasma oxygen concentration is in the range of 10(-5) M, insufficient to sustain metabolism. Oxygen carriers, present in blood, release oxygen into plasma, thereby replacing consumed oxygen and buffering PO2 near their P-50. They are the natural cell-bound carriers, like hemoglobin inside red cells, myoglobin inside myocytes, and artificial cell-free hemoglobin-based oxygen carriers (HBOC) dissolved in plasma. Metabolic oxygen replacement can be defined as cell-bound and cell-free delivery. Cell-bound delivery is retarded by the slow diffusion of oxygen in plasma and interstitial fluids. The 40% hematocrit of normal blood compensates for the delay, coping with the fast oxygen consumption by mitochondria. Facilitated oxygen diffusion by HBOCs corrects for the slow diffusion, making cell-free delivery relatively independent from P50. At all oxygen affinities, HBOCs produce hyperoxygenations that are compensated by vasoconstrictions. There is a strict direct correlation between the rate of oxygen replacement and hemoglobin content of blood. The free energy loss of the gradient adds a relevant regulation of tissues oxygenation. Oxygen is retained intravascularly by the limited permeability to gases of vessel walls. (C) 2009 Elsevier B.V. All Fights reserved.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [31] Artificial Oxygen Carriers: A Clinical Point of View
    Kawaguchi, Akira T.
    ARTIFICIAL ORGANS, 2009, 33 (02) : 97 - 99
  • [32] Artificial Oxygen Carriers Can Do More Than Just Deliver Oxygen
    Baeumler, Hans
    TRANSFUSIONSMEDIZIN, 2020, 10 (04) : 199 - 207
  • [33] Artificial Oxygen Carriers (Hemoglobin-Vesicles) as a Transfusion Alternative and for Oxygen Therapeutics
    Sakai, H.
    5TH KUALA LUMPUR INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING 2011 (BIOMED 2011), 2011, 35 : 845 - 848
  • [34] Biomimetic Nanoemulsions for Oxygen Delivery In Vivo
    Zhuang, Jia
    Ying, Man
    Spiekermann, Kevin
    Holay, Maya
    Zhang, Yue
    Chen, Fang
    Gong, Hua
    Lee, Joo Hee
    Gao, Weiwei
    Fang, Ronnie H.
    Zhang, Liangfang
    ADVANCED MATERIALS, 2018, 30 (49)
  • [35] From artificial red blood cells, oxygen carriers, and oxygen therapeutics to artificial cells, nanomedicine, and beyond
    Chang, Thomas M. S.
    ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY, 2012, 40 (03): : 197 - 199
  • [36] New Approaches in Commercial Development of Artificial Oxygen Carriers
    Simoni, Jan
    ARTIFICIAL ORGANS, 2014, 38 (08) : 621 - 624
  • [37] MODIFIED HEMOGLOBIN-SOLUTIONS AS ARTIFICIAL OXYGEN CARRIERS
    LENZ, G
    BISSINGER, U
    INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN, 1994, 21 : 63 - 67
  • [38] Artificial oxygen carriers - A critical analysis of current developments
    Dinkelmann, S
    Northoff, H
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2003, 38 (01): : 47 - 54
  • [39] Hemoglobin-vesicles (HbV) as artificial oxygen carriers
    Sakai, H
    Sou, K
    Takeoka, S
    Kobayashi, K
    Tsuchida, E
    ARTIFICIAL OXYGEN CARRIER: ITS FRONT LINE, 2005, 12 : 135 - 168
  • [40] Blood substitutes artificial oxygen carriers: perfluorocarbon emulsions
    Spahn, DR
    CRITICAL CARE, 1999, 3 (05): : R93 - R97